Researchers from DZNE and Ulm University Hospital have identified a protein in the blood that may indicate the degradation of neural connections years before the onset of dementia symptoms. If these findings are confirmed, recording this protein called “beta-synuclein” could contribute to the early detection of Alzheimer’s disease and possibly also help to assess nerve damage resulting from stroke or traumatic brain injury.
You may also be interested in:
A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and [...]
It’s not the mobile that makes children hyperactive, but the other way round: a fidgety child will use a mobile phone more—according to the latest [...]
A lifeguard shortage in many parts of the U.S. means an increased drowning risk at pools and beaches this summer. Earlier this summer, SciLine interviewed [...]